U.S. Trade Distributors Stock News

Lucid Group (NasdaqGS:LCID) is shifting its long term focus toward software and autonomous driving partnerships, aiming to prioritize software and AI development over pure vehicle sales. The company has entered a major partnership with Uber and Nuro to deploy a large fleet of autonomous premium EVs, supported by a substantial investment from Uber. Lucid is making several high level executive appointments to strengthen global supply chain and engineering leadership as it works to execute this...

If you are wondering whether Revolution Medicines at around US$99.79 is priced for its future potential or getting ahead of itself, you are in the right place for a clear look at what the current valuation is really telling you. The stock has had a mixed run recently, with a 1.8% gain over the last 7 days, a 17.0% decline over the past month, a 26.3% year to date return, and 135.7% over the last year, along with a very large 3 year return that sits just under 3x. These moves sit against a...

Idaho rate case puts Avista (AVA) in focus Avista (AVA) has filed for an annual electric rate adjustment with the Idaho Public Utilities Commission, seeking a 7.4% revenue increase tied to funding electric energy efficiency programs. See our latest analysis for Avista. Avista’s recent Idaho rate case comes as the stock’s share price return is up 4.95% over 30 days and 8.91% year to date, while its 1 year total shareholder return of 18.58% points to steady, if moderate, momentum rather than a...

Kohl’s recently introduced a new “Deal Bar” section at the front of all its stores, offering gifts, seasonal items, and everyday essentials priced at US$10 or less to appeal to cost-conscious shoppers. This move underlines Kohl’s push to revive store traffic by foregrounding sharply priced impulse and necessity purchases as consumers trim discretionary spending. Next, we’ll examine how the new under-US$10 Deal Bar concept could influence Kohl’s turnaround-focused investment narrative and...

If you are wondering whether Hims & Hers Health at around US$15.84 is starting to look attractive, you are not alone in asking what the current price really gets you. The share price has pulled back sharply, with a 5.1% decline over the last 7 days, a 49.5% decline over the last 30 days, and a 52.6% decline year to date, even though the 3 year return sits at 70.5%. Over the past year, the stock has also recorded a 77.0% decline, and the 5 year return stands at a 5.9% decline, which has...

In the days leading up to its recent earnings release, Guardant Health, a liquid biopsy specialist, drew increased attention after previously reporting US$265.2 million in quarterly revenue, up strongly year on year and ahead of analyst expectations. Institutional investors have been highlighting Guardant Health’s progress on FDA submissions, reimbursement expansion, and margin improvement, which together suggest meaningful operational momentum despite ongoing concerns about scale and...

Sherwin-Williams (NYSE:SHW) is facing a new class action lawsuit in California. The suit alleges violations of labor laws, including unpaid minimum and overtime wages. Claims also include denial of required meal and rest breaks and related wage and hour issues. The case raises questions about employment practices and potential legal liabilities for the company. Sherwin-Williams, a major paints and coatings producer, is closely tied to housing, construction, and maintenance activity. Many...

A recent Los Angeles jury verdict tied to toxic hydrogen sulfide gas exposure at a Prologis (PLD) warehouse has put the company’s legal risks in focus, with multimillion dollar damages and thousands of related claims pending. See our latest analysis for Prologis. At a share price of $139.63, Prologis has seen a 13.41% 90 day share price return and an 18.89% 1 year total shareholder return, suggesting positive momentum as the recent legal verdict and a 6% dividend increase reshape how...

Wondering if AES at US$16.29 is still offering value after its recent run, or if the easy money has already been made? This article is here to help you size that up calmly and clearly. The stock has returned 14.8% over the last 30 days and 65.6% over the last year, while the 3-year and 5-year returns of 26.4% and 29.7% declines show that the longer term picture has been very different. Recent news flow around AES has focused on its position in US utilities, including how investors are...

World Kinect Corporation recently reported Q4 EPS of US$0.54, missing analyst estimates by 11% for a third straight quarter amid ongoing margin pressure and revenue declines, while confirming that CFO and President Ira Birns will take over as CEO from 1 January 2026. This combination of recurring earnings disappointments, leadership change, and management’s interest in acquisitions to support EPS has sharpened questions about the company’s ability to rely on its core operations for future...

IMAX (IMAX) is back in the spotlight as it prepares an exclusive theatrical debut for Baz Luhrmann’s Elvis Presley concert documentary, alongside two-day 50th anniversary IMAX screenings of The Who’s rock opera film Tommy. See our latest analysis for IMAX. At a share price of US$37.80, IMAX has logged a 6.78% 3 month share price return and a 38.87% 1 year total shareholder return, and recent box office events and premium content partnerships appear to be contributing to gradually building...

Viper Energy (NasdaqGS:VNOM) is acquiring Sitio Royalties, expanding its royalty footprint in US shale. The company plans to sell its non Permian assets, sharpening its focus on its core basin. Management is working on integrating Sitio's assets into Viper's no capex royalty model. Analysts are highlighting how the combined royalty portfolio could affect future cash generation and distributions. Viper Energy, trading at $44.61, has seen its share price move 20.8% over the past month and...

Applied Materials, Inc. recently reported fiscal Q1 2026 results showing sales of US$7,012 million and net income of US$2,026 million, while also settling a US$252.5 million export-control matter with the U.S. Department of Commerce and receiving no-action closures from the Department of Justice and SEC. At the same time, the company is leaning into the AI infrastructure buildout with new 2nm-and-beyond chipmaking tools, a US$5.00 billion EPIC R&D center joined by Samsung, and guidance for...

CRH plc has reported its fourth-quarter and full-year 2025 results, with revenue of US$9,416 million and net income of US$1,025 million in Q4, alongside a 5% increase in the quarterly dividend to US$0.39 per ordinary share and the completion of a large share buyback phase totaling 77,073,466 shares since 2023. Alongside filing its 2025 Annual Report, CRH issued 2026 guidance for net income of US$3.90 billion to US$4.10 billion and diluted EPS of US$5.60 to US$6.05, while launching a new...

If you are trying to figure out whether Robinhood Markets' current share price lines up with its underlying worth, you are in the right place. The stock recently closed at US$75.21, with a 3.5% decline over the last 7 days, a 30.8% decline over 30 days, a 34.7% decline year to date, a 27.0% return over 1 year and a very large positive return over 3 years. Recent headlines around Robinhood have focused on its role in retail trading, regulatory attention on trading platforms and the continued...

Motorola Solutions (MSI) is back in focus after its fourth quarter 2025 report and outlook triggered a sharp stock move, with investors reacting to double digit revenue growth and earnings that surpassed market expectations. See our latest analysis for Motorola Solutions. The 7.7% jump in the share price immediately after the Q4 release, followed by a recent 7 day share price return of 7.24% and 30 day return of 12.73%, suggests building momentum on top of a 3 year total shareholder return of...

If you are looking at Molson Coors Beverage and wondering whether the current share price lines up with its underlying worth, you are in the right place. The stock closed at US$50.82, with a 7 day return of a 4.6% decline, a 30 day return of 3.8%, a year to date return of 7.2%, a 1 year return of a 12.4% decline, a 3 year return of 5.5% and a 5 year return of 24.2%. Taken together, these figures give a mixed picture of how the market has priced it over different time frames. Recent coverage...

Coherent (NYSE:COHR) executives plan to participate in high profile sessions at OFC 2026, a major optical networking conference. The company will host a Technology Innovation Briefing focused on photonics, optical networking, and its technology roadmap. Senior leaders including the CEO and CTO are expected to outline key themes around future products and platforms. For you as an investor, OFC 2026 is a useful window into how Coherent positions its photonics and optical networking portfolio...

Amneal Pharmaceuticals, Inc. announced that it has been added to the S&P SmallCap 600 Index and, in a separate move, entered into a research collaboration and option agreement with KeifeRx to develop KFRX06, a preclinical candidate targeting the LRRK2 gene linked to Parkinson's disease. These developments could broaden Amneal’s investor base through index inclusion while expanding its neuroscience pipeline via early-stage Parkinson’s research. Next, we’ll explore how joining the S&P SmallCap...

Pacific Ridge Capital Partners has fully exited its position in AXT (NasdaqGS:AXTI), removing a major institutional shareholder from the register. The divestment comes shortly after AXT reported a revenue turnaround at a time when the company is facing headwinds from China related export restrictions. This shift in ownership occurs as AXT continues to operate under heightened policy and trade scrutiny that directly affects parts of its business. AXT, which supplies compound semiconductor...

Why CF Industries Holdings (CF) just caught the market’s attention CF Industries Holdings (CF) reported fourth quarter and full year 2025 results with higher sales and net income versus the prior year, along with adjusted earnings that topped analyst expectations despite a US$76 million asset impairment. See our latest analysis for CF Industries Holdings. The earnings beat and higher reported sales and net income sit alongside a strong 90 day share price return of 23.18% and a 1 year total...

Constellium FY 2025 Results: Revenue Steady, Earnings Volatile Constellium (CSTM) just posted another quarter of mixed numbers, with Q3 2025 revenue at US$2.2b, basic EPS of US$0.63 and net income of US$88m. The latest trailing twelve month figures show revenue of about US$8.0b and EPS of US$0.80 alongside a net margin of 1.4% compared to 1.8% the prior year. Over recent quarters, the company has seen revenue move from US$1.8b in Q3 2024 to US$2.2b in Q3 2025. Quarterly EPS has swung from a...

Why Jack Henry & Associates (JKHY) is back in focus Recent analyst sentiment around Jack Henry & Associates (JKHY) has turned more constructive, coinciding with fresh news on its dividend policy, share repurchases, and a new client relationship with Blue Sky Bank. This mix of capital returns and business wins gives you several concrete data points to consider as you think about how JKHY fits into a portfolio focused on financial technology and payment services. See our latest analysis for...

Why Pediatrix Medical Group is on investors’ radar today Pediatrix Medical Group (MD) released Q4 and full year 2025 results showing lower sales alongside higher net income and earnings per share, catching investor attention as the market absorbs this mixed top and bottom line picture. See our latest analysis for Pediatrix Medical Group. The latest move in Pediatrix Medical Group’s share price to US$21.97 comes after a year where shorter term share price returns were mixed, while the 1 year...